Literature DB >> 23623852

In vivo phage display--a discovery tool in molecular biomedicine.

Janka Bábíčková1, Ľubomíra Tóthová, Peter Boor, Peter Celec.   

Abstract

In vivo phage display is a high-throughput method for identifying target ligands specific for different vascular beds. Targeting is possible due to the heterogeneous expression of receptors and other antigens in a particular vascular bed. Such expression is additionally influenced by the physiological or pathological status of the vasculature. In vivo phage display represents a technique that is usable in both, vascular mapping and targeted drug development. In this review, several important methodological aspects of in vivo phage display experiments are discussed. These include choosing an appropriate phage library, an appropriate animal model and the route of phage library administration. In addition, peptides or antibodies identified by in vivo phage display homing to specific types of vascular beds, including the altered vasculature present in several types of diseases are summarized. Still, confirmation in independent experiments and reproduction of identified sequences are needed for enhancing the clinical applicability of in vivo phage display research.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular medicine; Peptide identification; Phage library; Screening; Targeting

Mesh:

Substances:

Year:  2013        PMID: 23623852     DOI: 10.1016/j.biotechadv.2013.04.004

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  21 in total

1.  RNAi therapies: drugging the undruggable.

Authors:  Sherry Y Wu; Gabriel Lopez-Berestein; George A Calin; Anil K Sood
Journal:  Sci Transl Med       Date:  2014-06-11       Impact factor: 17.956

2.  Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes.

Authors:  Kai K Ewert; Venkata Ramana Kotamraju; Ramsey N Majzoub; Victoria M Steffes; Emily A Wonder; Tambet Teesalu; Erkki Ruoslahti; Cyrus R Safinya
Journal:  Bioorg Med Chem Lett       Date:  2016-02-04       Impact factor: 2.823

3.  Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo.

Authors:  Emily Wonder; Lorena Simón-Gracia; Pablo Scodeller; Ramsey N Majzoub; Venkata Ramana Kotamraju; Kai K Ewert; Tambet Teesalu; Cyrus R Safinya
Journal:  Biomaterials       Date:  2018-03-02       Impact factor: 12.479

Review 4.  Bacteriophage-based biomaterials for tissue regeneration.

Authors:  Binrui Cao; Yan Li; Tao Yang; Qing Bao; Mingying Yang; Chuanbin Mao
Journal:  Adv Drug Deliv Rev       Date:  2018-11-16       Impact factor: 15.470

Review 5.  Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.

Authors:  Valery A Petrenko; James W Gillespie
Journal:  Expert Opin Drug Deliv       Date:  2016-08-05       Impact factor: 6.648

Review 6.  Homing Peptides for Cancer Therapy.

Authors:  Prakash Lingasamy; Tambet Teesalu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Phage display: development of nanocarriers for targeted drug delivery to the brain.

Authors:  Babak Bakhshinejad; Marzieh Karimi; Mohammad Khalaj-Kondori
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

8.  Advancement and applications of peptide phage display technology in biomedical science.

Authors:  Chien-Hsun Wu; I-Ju Liu; Ruei-Min Lu; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2016-01-19       Impact factor: 8.410

Review 9.  Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.

Authors:  Zhigang Ju; Wei Sun
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Phage Peptide Libraries As a Source of Targeted Ligands.

Authors:  A A Nemudraya; V A Richter; E V Kuligina
Journal:  Acta Naturae       Date:  2016 Jan-Mar       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.